FDA Approves Ocular Implant for Vision-Threatening MacTel

[ad_1]

(MedPage Today) — The FDA approved revakinagene taroretcel (Encelto) as the first treatment for adults with idiopathic macular telangiectasia (MacTel) type 2, Neurotech Pharmaceuticals announced on Thursday.
A rare, progressive neurodegenerative…

[ad_2]

Source link : https://www.medpagetoday.com/ophthalmology/generalophthalmology/114553

Author :

Publish date : 2025-03-07 22:02:00

Copyright for syndicated content belongs to the linked Source.